Quince Therapeutics, Inc. (QNCX)
0.1065
0.00 (0.00%)
USD |
NASDAQ |
Mar 13, 16:00
0.101
-0.01
(-5.16%)
After-Hours: 20:00
Quince Therapeutics Total Liabilities (Quarterly) : 108.84M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Recursion Pharmaceuticals, Inc. | 397.49M |
| Ocular Therapeutix, Inc. | 156.83M |
| Gossamer Bio, Inc. | 291.15M |
| Ernexa Therapeutics, Inc. | 2.602M |
| Acurx Pharmaceuticals, Inc. | 2.421M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 109.90M |
| Shareholders Equity (Quarterly) | 1.059M |
| Debt to Equity Ratio | 16.99 |
| Current Ratio | 1.121 |
| Net Debt Paydown Yield | -0.81% |